EFFICACY AND SAFETY OF ADALIMUMAB IN PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A RANDOMIZED-CONTROLLED PHASE 3 STUDY

Nicholas M. Croft  ¹     William A Faubion  ²     Subra Kugathasan  ³     Jaroslaw Kierkus  ⁴     Frank Ruemmele  ⁵     Nael M. Mostafa  ⁶     Mary Venetucci  ⁶     Tricia Finney-Hayward  ⁶     Mareike Bereswill  ⁷     Andreas Lazar  ⁷     Dan Turner  ^8    
1 Queen Mary University of London, London, United Kingdom
² Mayo Clinic, Rochester, United States
³ Emory University School of Medicine and Children’s Health Care of Atlanta, Atlanta, United States
⁴ Children's Memorial Health Institute, Warsaw, Poland
⁵ Université de Paris, Paris, France
⁶ AbbVie, North Chicago, United States
⁷ AbbVie Deutschland, Ludwigshafen, Germany
⁸ Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel

Topic
IBD, Immunology, Paediatrics

Session
IBD: Mixed trials

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)